PICU Satellite Pharmacy
Opened in 1984 by Drs. Powell and Rajanna (Raj), the PICU Satellite Pharmacy at Le Bonheur Children's Hospital was the first-ever pediatric critical care satellite pharmacy in the region. Now as a 24/7 operation, it provides pediatric clinical pharmacy specialists to the patients and the PICU team. Being located in the PICU, clinical pharmacists are available for immediate face-to-face consultation regarding any medication-related issues - whether during weekdays, or nights, weekends and holidays.
They also respond to emergencies by preparing resuscitative medications at the patient's bedside. Clinical pharmacists participate in daily multidisciplinary rounds and provide services including, but not limited to, medication dispensing, drug monitoring (pharmacokinetics), assistance with pain management, drug information, general clinical pharmacology, anticoagulation, assistance with antibiotic therapies, and management of sedative medications.
The PICU Satellite Pharmacy serves as a training center for pharmacy students (P-3 and P-4) and pharmacy residents (PGY-1 and PGY-2) and also provides nursing and physician education. Clinical pharmacists also participate in research projects and have presented numerous poster and platform presentations locally, regionally, and nationally; furthermore, members of the PICU Clinical Pharmacy Staff have authored or co-authored numerous publications.
Full Time Staff
Clinical Pharmacists
- Laura Broome, PharmD, BCPS
- Bess Flynn, PharmD, BCPS
- Eddie Hankins, PharmD
- Cindy Hanson, PharmD
- Amanda Helton-Clark, PharmD
- Katie McCallister, PharmD
- Steve McCommon, PharmD
- Becky McGee, DPh
- Pamela Murray, PharmD
- Kerri Parks, PharmD
- Mark Rayburn, PharmD
- Jessica Rosson, PharmD, BCPS
- Jasmine Sahni, PharmD, BCPS
Certified Pharmacy Technicians
- Candance Brodnax, CPhT
- Faith Patterson, CPhT
- Krystal Sain, CPhT
- Brittney Smith, CPhT
Publications
Drago BB, Kimura D, Rovnaghi CR, Schwingshackl A, RayburnM, Meduri U, and Anand KJS. "Methylprednisolone Infusion in Pediatric ARDS: Results from a Double-Blind, Placebo-Controlled Randomized Trial." (Submitted to Pediatric Critical Care Medicine, April 2014; pending revisions)
McCallister KM, Chhim RF, Briceno-Medina M, Shelton CM, Figueroa M, and Rayburn M. "Comparison of bumetanide continuous infusions to furosemide continuous infusions in critically ill pediatric patients." (Accepted for publication by Pediatric Critical Care Medicine, August 2014; publication pending)
Jones RC, Rajasekaran S, Rayburn M, Tobias JD, Kelsey RM, Wetzel GT, Cabrera AG. "Initial experience with conivaptan use in critically ill infants with cardiac disease." J Pediatr Pharmacol Ther. 2012 Jan;17(1):78-83.
Spentzas T, Shapley RKH, Aguirre CA, Meals E, Lazar L, Rayburn MS, Walker BS, English BK. "Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus." BMC Immunol. 2011 Jan 25;12:11.
Sahni JK, Phelps SP. "Nebulized Furosemide in the Treatment of Bronchopulmonary Dysplasia in Preterm Infants". J Pediatr Pharmacol Ther. 2011;16(1):14-22.
Hicks JK, Shelton CM, Sahni JK, Christensen ML. "Retrospective Evaluation of Enoxaparin Dosing in Patients 48 weeks’ Postmenstrual Age or Younger in a Neonatal Intensive Care Unit".Ann Pharmacother 2012;46(7-8):943-51.